Encainide

CHEMBL315838 Phase 4 Approved Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

352.5 g/mol

LogP

4.3

Phase

4

This medication slows electrical signals in the heart to treat certain types of abnormal heart rhythms. It works by blocking sodium channels in heart muscle cells.

Molecular Weight

352.5000 g/mol

LogP

4.30

TPSA

41.60 Å²

Lipinski RO5

Pass

Therapeutic Areas

Cardiovascular Disease

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Structure

SVG PNG

Cite this structure

Embed this structure

SMILES

COc1ccc(C(=O)Nc2ccccc2CCC2CCCCN2C)cc1

InChI

InChI=1S/C22H28N2O2/c1-24-16-6-5-8-19(24)13-10-17-7-3-4-9-21(17)23-22(25)18-11-14-20(26-2)15-12-18/h3-4,7,9,11-12,14-15,19H,5-6,8,10,13,16H2,1-2H3,(H,23,25)

Molecular Formula

C22H28N2O2

HBD / HBA

1 / 3

Rotatable Bonds

6

Heavy Atoms

26

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

This medication slows electrical signals in the heart to treat certain types of abnormal heart rhythms. It works by blocking sodium channels in heart muscle cells.

Yes, Encainide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL315838. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 48041. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Looking for patient-friendly information?

Encainide on PillFYI

Structure

Quick Data

Formula: C22H28N2O2

External Links

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.